Eupraxia Pharmaceuticals (EPRX) Treasury Shares (2022 - 2025)
Eupraxia Pharmaceuticals (EPRX) posted quarterly Treasury Shares of $8.0 million for Q4 2025, down 30.22% quarter-over-quarter from $11.5 million in Q4 2022.
Eupraxia Pharmaceuticals (EPRX) Treasury Shares (2022 - 2025) Analysis & Trends
Eupraxia Pharmaceuticals (EPRX) has reported Treasury Shares for 2 consecutive years, with $8.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Treasury Shares changed N/A year-over-year to $8.0 million; the TTM figure through Dec 2025 stood at $8.0 million (changed N/A YoY), while the FY2025 annual figure was $8.0 million, changed N/A from the prior year.
- Treasury Shares slipped to $8.0 million in Q4 2025 per EPRX's latest filing, from $11.5 million in the prior quarter.
- Across five years, Treasury Shares topped out at $11.5 million in Q4 2022 and bottomed at $8.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Eupraxia Pharmaceuticals | 381.11 Mn | 379.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.03 Mn |
| Dec 31, 2025 | 8.03 Mn |
| Dec 31, 2022 | 11.50 Mn |
| Dec 31, 2022 | 11.50 Mn |